The level of MDC1, a critical component in DNA damage response, was shown to be aberrantly reduced in 30% of breast carcinoma tissues34, and its expression was further suggested as a prognostic marker in early-stage breast cancer35. Here, MDC1 is linked to breast carcinoma.